A retrospective analysis of hospital treatment expenditures among young and middle age patients with cancer, 2013-2017 under health reform.
cancer
health reform
hospital treatment expenditures
young and middle age patients
Journal
The International journal of health planning and management
ISSN: 1099-1751
Titre abrégé: Int J Health Plann Manage
Pays: England
ID NLM: 8605825
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
25
10
2019
accepted:
28
10
2019
pubmed:
7
1
2020
medline:
11
5
2021
entrez:
7
1
2020
Statut:
ppublish
Résumé
Under 60 year olds represent a rapidly growing segment of the cancer population. They often face longer hospital stays, higher treatment intensity, and hospitalization costs. In this background, we aim to assess the impact of the 2009 reforms on the hospital expenses of younger cancer inpatients. Our study sample included 11 791 young and middle age stomach, lung, colorectal, esophageal, and breast cancer inpatients hospitalized during 2013 to 2017. Hospitalization treatment costs of under 60 cancer inpatients increased, but it fell in 2017 under the impact of the health reforms. However, out-of-pocket expenditures rose, which partly reflected the failure of the health insurance scheme to adequately cover cancer inpatient cost, potentially imposing financial hardships on cancer inpatients and their families. To continue to reduce the economic burden of cancer patients, early screening and diagnosis among younger populations and enhanced hospice care integrated with the ongoing primary health care reform are important.
Types de publication
Journal Article
Langues
eng
Pagination
878-887Informations de copyright
© 2020 John Wiley & Sons, Ltd.
Références
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global Cancer Statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;0:1-31.
Chen WQ, Sun KX, Zheng RS, et al. Cancer incidence and mortality in China, 2014. Chin J Cancer Res. 2018;30(1):1-12.
Yu K, Di GJ, Lu J, et al. Breast cancer patients with estrogen receptor-negative/progesterone receptor-positive tumors: being younger and getting less benefit from adjuvant tamoxifen treatment. EJC Suppl. 2008;6(12):1347-1354.
Metcalfe K. Young people living with cancer-By Anne Grinyer. Health & Social Care in the Community. 2008;16(5):562-563.
Rahman R, Schmaltz C, Jackson CS, Simoes EJ, Jackson-Thompson J, Ibdah JA. Increased risk for colorectal cancer under age 50 in racial and ethnic minorities living in the United States. Cancer Med. 2015;4(12):1863-1870.
Banegas MP, Yabroff KR, O'Keeffe-Rosetti MC, et al. Medical care costs associated with cancer in integrated delivery systems. J Natl Compr Canc Netw. 2018;16(4):402-410.
Abelsattar ZM, Wong SL, Regenbogen SE, Jomaa DM, Hardiman KM, Hendren S. Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. Cancer. 2016;122(6):929-934.
Banegas M, Yarbrough KR, Okeeffe-Rosetti M, et al. Medical care costs associated with cancer in integrated delivery systems. J Natl Compr Canc Netw. 2018;16(4):402-410.
Shankaran V, Jolly S, Blough D, Ramsey SD. Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol. 2012;30(14):1608-1614.
Maniatopoulos G, Llewellyn S, Procter R, et al. Negotiating technological innovation in health care. Proceedings of the European Group for Organisational Studies Colloquium, 2011.
Wei X, Zou G, Zhang H, et al. Implementation of the Chinese national microscopy centre policy: health facility survey in Shandong Province. Trop Med Int Health. 2011;16(7):847-853.
Hu R, Liao Y, Du Z, Hao Y, Liang H, Shi L. Types of health care facilities and the quality of primary care: a study of characteristics and experiences of Chinese patients in Guangdong Province, China. BMC Health Serv Res. 2016;16(a):335.
Jeannon JP, Abbs I, Calman F, et al. Implementing the National Institute of Clinical Excellence improving outcome guidelines for head and neck cancer: developing a business plan with reorganisation of head and neck cancer services. Clin Otolaryngol. 2010;33(2):149-151.
Barber SL, Borowitz M, Bekedam H, Ma J. The hospital of the future in China: China's reform of public hospitals and trends from industrialized countries. Health Policy Plan. 2014;29(3):367-378.
Hu S, Tang S, Liu Y, Zhao Y, Escobar ML, De Ferranti D. Reform of how healthcare is paid for in China: challenges and opportunities. Lancet. 2008;372(9652):1846-1853.
Yip WC, Hsiao WC, Chen W, Hu S, Ma J, Maynard A. Early appraisal of China's huge and complex health-care reforms. Lancet. 2012;379(9818):833-842.
Health commission of Shandong Province. Health Statistics Yearbook of Shandong Province. Shenzhen: China Tushu Publishing Limited; 2016; 2016.
Tang W, Xie J, Lu Y, et al. Effects of Chinese urban public hospitals reform on revenue and compensation after removing drug markups: case of Nanjing. J Med Econ. 2017;1-31.
Zhao H. China's health insurance reform and disparities in healthcare utilization and costs: a longitudinal analysis. Ann Arbor: Dissertations & Theses - Gradworks; 2015.
National Bureau of Statistics of China. China statistical yearbook 2016. Beijing: China Statistics Press; 2016.
Xu J, Wang J, Liu R, et al. Mental health inpatient treatment expenditure trends in China, 2005-2012: evidence from Shandong. J Ment Health Policy Econ. 2014;17(4):173-182.
The impact of China's Zero-Markup Drug Policy on county hospital revenue and government subsidy levels. Journal of Asian Public Policy. 2015;8(1):102-116.
Cohen D. Cancer drugs: high price, uncertain value. BMJ. 2017;j4543.
Liu X, Liu Y, Chen N. The Chinese experience of hospital price regulation. Health Policy Plan. 2000;15(2):157-163.
Liu X. The Chinese experience of hospital price regulation. Health Policy Plan. 2000;15(2):157-163.
Experts in Chronic Myeloid Leukemia. The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts. Blood. 2013;121(22):4439-4442.
Ko Y, Gwee YS, Huang YC, Chiang J, Chan A. Costs and length of stay of drug-related hospital admissions in cancer patients. Clin Ther. 2014;36(4):588-592.
Xu J, Wang J, King M, et al. Rural-urban disparities in the utilization of mental health inpatient services in China: the role of health insurance. Int J Health Econ Manag. 2018;18(4):377-393.